Ronald C Gobeil, DO Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 200 High Service Avenue, Marian Hall 1st Floor, North Providence, RI 02904 Phone: 401-456-3649 Fax: 401-752-8116 |
Robert James Zielinski, Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 17 Hunters Run, North Providence, RI 02904 Phone: 401-323-8065 |
Dr. Rodrigo Nardi, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 200 High Service Ave, North Providence, RI 02904 Phone: 401-456-3000 |
News Archive
Chamberlin Edmonds and Associates, Inc., a leading provider of comprehensive patient eligibility services to hospitals, today announced that it was selected by Sky Lakes Medical Center (Klamath Falls, Ore.) to help improve patient access to state and federal benefit programs. Eligibility specialists from Chamberlin Edmonds will work at the hospital to guide patients through complex application processes to secure federal and state benefits for medical care.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced that a Phase 3 trial evaluating Nexavar (sorafenib) tablets in patients with advanced relapsed or refractory non-squamous non-small cell lung cancer (NSCLC) whose disease progressed after two or three previous treatments, did not meet its primary endpoint of improving overall survival.
DUSA Pharmaceuticals, Inc.(R)( )(Nasdaq: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that it has been named to Deloitte's Technology Fast 500 list. For the second consecutive year, Deloitte recognized DUSA as one of the Top 500 fastest growing technology, media, telecommunications and life sciences companies in North America in terms of percentage revenue growth over a five year period.
In an important, comprehensive, and timely review, an expert team from the University of California Berkeley details the methodologies used in nucleic acid-based tests for detecting the presence of SARS-CoV-2, the virus that causes COVID-19.
› Verified 6 days ago